A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Timothy Perren, Ann Marie Swart, Jacobus Pfisterer, +23

New England Journal of Medicine

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

Andreas du Bois, Eric Pujade‐Lauraine, Philipp Harter, +2

Cancer

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Amit M. Oza, Adrian Cook, Jacobus Pfisterer, +21

The Lancet Oncology

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Andreas du Bois, Michael Quinn, Tate Thigpen, +40

Annals of Oncology

MedicineCancer ManagementReproductive HealthGynecologyGcig Occc 2004 +7

The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

Lars Hanker, Sibylle Loibl, Nicole Burchardi, +7

Annals of Oncology

MedicinePrimary Taxane/platinum-based TherapyGynecologyLine TherapyRelapsed Ovarian Cancer +6

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Dan Stark, Matthew Nankivell, Éric Pujade-Lauraine, +16

The Lancet Oncology

International CollaborationMedicineStandard ChemotherapyCancer ManagementMetronomic Therapy +9

Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer

Norbert Arnold, Lorenz Hägele, Lioba Walz, +4

Genes Chromosomes and Cancer

Microsatellite instability in ovarian neoplasms

Maria Luisa Carcangiu, D. Carter, Marion Kiechle, +3

British Journal of Cancer

GeneticsGynecologyFemale Reproductive SystemReproductive BiologyPublic Health +3

Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum/Paclitaxel–Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group

Christina Fotopoulou, Andreas duBois, Alexandros N. Karavas, +5

Journal of Clinical Oncology

Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers

Robertson Mackenzie, Aline Talhouk, Sima Eshragh, +15

The American Journal of Surgical Pathology

Endocrine-related CancerEpithelial Ovarian CancerMedicineHistopathologyPathology +9